四肢尤文肉瘤的跳跃转移与远处转移、化疗反应及总生存的关系
跳跃转移与初诊时肺转移显著相关(p=0.02),且与更差生存显著相关(p=0.007),死亡风险为无跳跃转移者的三倍。跳跃转移与远处骨转移、化疗反应、肿瘤长度及骨外病变均无显著相关。
要点
- 全骨MRI发现跳跃转移时,需警惕初诊肺转移可能。
- 跳跃转移提示预后不良,死亡风险约增三倍。
- 跳跃转移与化疗反应、肿瘤长度及骨外病变无显著相关。
关键影像表现/征象
- 全骨MRI上80例(84.2%)无跳跃转移,15例(15.8%)有一个或多个跳跃转移。
- 无跳跃转移者中肺转移16例(21%)、远处骨转移7例(11%),有跳跃转移者中分别为7例(50%)、3例(27%)。
诊断标准与关键数值
- 跳跃转移与肺转移显著相关(p=0.02),与远处骨转移无显著相关(p=0.13)。
- 跳跃转移与化疗反应(p=0.88)、肿瘤长度(p=0.47)、骨外病变存在(p=0.15)及轴位深度(p=0.4)均无显著相关。
- 跳跃转移与显著更差生存相关(p=0.007),随访期间死亡风险为三倍。
- 无跳跃转移者化疗良好反应51例(75%),有跳跃转移者10例(77%)。
临床应用与阅片要点
- 四肢尤文肉瘤应行全骨MRI以检出跳跃转移。
- 发现跳跃转移时,应警惕合并肺转移并提示预后不良。
局限性
- 回顾性研究设计。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To identify in appendicular Ewing sarcoma (ES), if skip metastases (SM) are associated with distant metastases at presentation, response to neoadjuvant chemotherapy and overall outcome.
MATERIALS AND METHOD: Patients with appendicular ES from 2007 to 2021 who had whole-bone MRI to identify SM were included in the study. Patient demographics included age/gender, bone involved, the presence of SM, longitudinal tumour length, presence of extra-osseous disease and its axial depth if present from whole-bone MRI and lung metastases and distant bone metastases from staging studies. Response to neoadjuvant chemotherapy from resection specimens and overall survival were noted. Comparison of these factors between patients with and without SM was undertaken.
RESULTS: Ninety-five patients (66 males; 29 females: mean age 15.8 years; range 5-48 years) were included. On whole-bone MRI, 80 (84.2%) patients had no SM and 15 (15.8%) patients had one or more SM. Of patients without a SM, lung metastases were present in 16 (21%), distant bone metastases in 7 (11%), while 51 (75%) had a good response to chemotherapy compared with 7 (50%), 3 (27%), and 10 (77%), respectively, in patients with a SM. SM were significantly associated with lung metastases (p = 0.02), but not with distant skeletal metastases (p = 0.13), chemotherapy response (p = 0.88), tumour length (p = 0.47), presence of (p = 0.15) or axial depth of extra-osseous disease (p = 0.4). SM were associated with a significantly poorer survival (p = 0.007) and three times greater risk of death during follow-up.
CONCLUSIONS: In appendicular ES, the identification of a SM is associated with the presence of lung metastases at presentation and poorer survival.
引用
- Saifuddin, Michelagnoli, Pressney, et al. Skip metastases in appendicular Ewing sarcoma: relationship to distant metastases at diagnosis, chemotherapy response and overall survival. Skeletal Radiol. 2022. PMID: 36100697. doi:10.1007/s00256-022-04180-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。